BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6710076)

  • 21. Effects of gliadin-derived peptides from bread and durum wheats on small intestine cultures from rat fetus and coeliac children.
    Auricchio S; De Ritis G; De Vincenzi M; Occorsio P; Silano V
    Pediatr Res; 1982 Dec; 16(12):1004-10. PubMed ID: 7155669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-specific cytotoxicity of wheat gliadin components towards cultured human cells.
    Hudson DA; Cornell HJ; Purdham DR; Rolles CJ
    Lancet; 1976 Feb; 1(7955):339-41. PubMed ID: 54743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical testing of bread made from nullisomic 6A wheats in coeliac patients.
    Ciclitira PJ; Hunter JO; Lennox ES
    Lancet; 1980 Aug; 2(8188):234-6. PubMed ID: 6105397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proceedings: Use of an improved jejunal culture system for the study of normal and coeliac mucosa.
    L'Hirondel C; Doe WF; Peters TJ
    Gut; 1975 May; 16(5):392. PubMed ID: 1140637
    [No Abstract]   [Full Text] [Related]  

  • 25. Cell-mediated immunity to gliadin within the small-intestinal mucosa in coeliac disease.
    Ferguson A; MacDonald TT; McClure JP; Holden RJ
    Lancet; 1975 Apr; 1(7912):895-7. PubMed ID: 47539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Barley and rye prolamins induce an mRNA interferon-gamma response in coeliac mucosa.
    Bracken SC; Kilmartin C; Wieser H; Jackson J; Feighery C
    Aliment Pharmacol Ther; 2006 May; 23(9):1307-14. PubMed ID: 16629935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wheat gliadin fractions and other cereal antigens reactive with antibodies in the sera of coeliac patients.
    Kieffer M; Frazier PJ; Daniels NW; Coombs RR
    Clin Exp Immunol; 1982 Dec; 50(3):651-60. PubMed ID: 7166001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activities of A-gliadin-related synthetic peptides: damaging effect on the atrophic coeliac mucosa and activation of mucosal immune response in the treated coeliac mucosa.
    Maiuri L; Troncone R; Mayer M; Coletta S; Picarelli A; De Vincenzi M; Pavone V; Auricchio S
    Scand J Gastroenterol; 1996 Mar; 31(3):247-53. PubMed ID: 8833354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gliadin induced changes in the expression of MHC-class II antigens by human small intestinal epithelium. Organ culture studies with coeliac disease mucosa.
    Fais S; Maiuri L; Pallone F; De Vincenzi M; De Ritis G; Troncone R; Auricchio S
    Gut; 1992 Apr; 33(4):472-5. PubMed ID: 1582589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intracellular transport of gliadins in enterocytes in celiac disease].
    Zimmer KP; Weber P; Böcker W; Schmid KW
    Verh Dtsch Ges Pathol; 1996; 80():213. PubMed ID: 9065006
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevention by mannan and other sugars of in vitro damage of rat fetal small intestine induced by cereal prolamin peptides toxic for human celiac intestine.
    Auricchio S; De Ritis G; De Vincenzi M; Latte F; Maiuri L; Pino A; Raia V; Silano V
    Pediatr Res; 1987 Dec; 22(6):703-7. PubMed ID: 3431955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An in vitro model for gluten enteropathy.
    Nutr Rev; 1980 Apr; 38(4):161-3. PubMed ID: 7207883
    [No Abstract]   [Full Text] [Related]  

  • 33. [Structure of small intestinal mucosa in children with celiac disease in different stages of the disease].
    Lysikov IuA
    Arkh Patol; 1995; 57(3):17-22. PubMed ID: 7677574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coeliac disease: in vivo toxicity of the putative immunodominant epitope.
    Fraser JS; Engel W; Ellis HJ; Moodie SJ; Pollock EL; Wieser H; Ciclitira PJ
    Gut; 2003 Dec; 52(12):1698-702. PubMed ID: 14633945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mannan and oligomers of N-acetylglucosamine protect intestinal mucosa of celiac patients with active disease from in vitro toxicity of gliadin peptides.
    Auricchio S; De Ritis G; De Vincenzi M; Magazzù G; Maiuri L; Mancini E; Minetti M; Sapora O; Silano V
    Gastroenterology; 1990 Oct; 99(4):973-8. PubMed ID: 2394351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucosal digestion studies of whole gliadin fractions in coeliac disease.
    Cornell HJ
    Ann Clin Biochem; 1990 Jan; 27 ( Pt 1)():44-9. PubMed ID: 2310157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relation between gliadin structure and its toxicity to glutensensitive patients.
    Hekkens WT
    Minerva Pediatr; 1977 Nov; 29(37):2191-6. PubMed ID: 600226
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention by a decapeptide from durum wheat of in vitro gliadin peptide-induced apoptosis in small-bowel mucosa from coeliac patients.
    Silano M; Leonardi F; Trecca A; Mancini E; Di Benedetto R; De Vincenzi M
    Scand J Gastroenterol; 2007 Jun; 42(6):786-7. PubMed ID: 17506006
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of gliadin on cholesterol synthesis of the enterocytes in celiac disease in children].
    Kuberger MB; Izachik NA; Izachik IuA
    Pediatriia; 1988; (11):15-9. PubMed ID: 3226797
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies in vivo of omega-gliadins in gluten sensitivity (coeliac sprue disease).
    Ensari A; Marsh MN; Moriarty KJ; Moore CM; Fido RJ; Tatham AS
    Clin Sci (Lond); 1998 Oct; 95(4):419-24. PubMed ID: 9748417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.